Downloads
Title
Source name
Date

Risk of Type 2 Diabetes In Children Increases Following SARS-CoV-2 Infection

The increase was observed across multiple subgroups, including those with overweight or obesity and hospitalized patients.

Pharmacy Times
16 Oct 2024

Pacritinib Demonstrates Efficacy, Tolerability in Patients with Myelofibrosis and Thrombocytopenia

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

Gepotidacin Receives FDA Priority Review for the Treatment of Uncomplicated Urinary Tract Infections

Gepotidacin could be first-in-class oral antibiotic treatment approved for uUTIs in over 20 years.

Pharmacy Times
16 Oct 2024

Loncastuximab Tesirine Demonstrates Promise in Managing Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-Cell Lymphoma

The results indicate the potential use of loncastuximab tesirine as a treatment option for the rare hyperinflammatory condition.

Pharmacy Times
16 Oct 2024

All News | Page 1310

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

Nicole McMullen, PharmD, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.

Pharmacy Times
16 Oct 2024

Jennifer Kolb

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

Building a Future Workforce: Pharmacies Partner with High Schools to Sponsor Students Through Pharmacy Tech Program

A projected shortage of trained staff in the years ahead demands looking beyond normal hiring channels.

Pharmacy Times
16 Oct 2024

Raymond DeMatteo, PharmD, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

Brigimadlin: A Novel MDM2-Targeted Therapy for Dedifferentiated Liposarcoma

The drug's safety profile included significant rates of nausea, vomiting, and hematologic toxicities like neutropenia and thrombocytopenia. Although promising, brigimadlin requires careful manage

Pharmacy Times
16 Oct 2024

Reemal Zaheer, PharmD

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

New Migraine Guidelines Aim to Help Patients Beat the Pain

The updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.

Pharmacy Times
16 Oct 2024

Yasmin Sheikh

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
16 Oct 2024

The UK Became a Leader in the Cell Therapy Revolution, but a Lack of Ongoing Investment Could Change That

Advanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, pat

Pharmacy Times
16 Oct 2024

FDA Approves Imuldosa, Ustekinumab Biosimilar For Treatment of Chronic Inflammatory Conditions

Imuldosa has received approval for all indications of its reference product, including ulcerative colitis, psoriatic arthritis, and Crohn disease.

Pharmacy Times
15 Oct 2024

High-Dose IVIG With Glucocorticoids Shown to Benefit Patients With Kawasaki Disease at High Risk For IVIG Resistance

Glucocorticoids improved outcomes for patients with Kawasaki disease at high risk of IVIG resistance without glucocorticoid-related adverse effects.

Pharmacy Times
15 Oct 2024

Pharmacist Survey: Opportunities Abound in Direct Patient Care, AI, and Personalized Medicine

Although respondents identified some exciting areas of growth, challenges remain, including the complex insurance system and ensuring patient medication adherence.

Pharmacy Times
15 Oct 2024

Pharmacy Technicians Are the “Glue” in the Pharmacy Space

Two MUSC pharmacy technicians discuss how techs are pivotal in pharmacy, whether in the community or clinical setting, and how it is important to maintain high standard of care in a changing environment.

Pharmacy Times
15 Oct 2024

Grashma Vadakkel, PharmD, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
15 Oct 2024

An Overview of SGLT2 Inhibitors in Heart Failure with Preserved Ejection Faction

Current guidelines recommend a backbone of SLGT2 therapy in patients with HFpEF who have no contraindications.

Pharmacy Times
15 Oct 2024

Breaking Barriers in Cancer Research: How Advocacy and Compassionate Care Enhance Clinical Trial Access

Terry Keys highlights the role of language and terminology as barriers for patients receiving cancer care.

Pharmacy Times
15 Oct 2024

Study: Inactivated Vaccines Prevent Influenza for Children, Remaining Effective After COVID-19 Pandemic

Investigators state that health care providers should consider the potential use of 2 doses to increase the effectiveness against influenza B.

Pharmacy Times
15 Oct 2024

Pharmacist Spotlight: Jess Fiant, PharmD, CSP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
15 Oct 2024

Anne Cassity

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
15 Oct 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept